Platelet-Based Breast Implant Contracture Relaxation Without Surgery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Capsular contractures around breast implants, particularly grades 3 and 4, cause significant pain and deformity, necessitating surgical intervention, and existing treatments like capsulectomy or capsulotomy are invasive.
Innovation Solution
Administering autologous platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) products to the capsular contracture, combined with acoustic sound waves or pulsed electric currents, to promote relaxation and reduce contracture severity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If surgical intervention (capsulectomy or capsulotomy) is performed to treat capsular contracture, then the contracture is removed or released, but the treatment is invasive and carries surgical risks
Solution Approach 1:
The patent replaces mechanical surgical intervention with a biochemical treatment system. Platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) is injected into the capsular contracture, utilizing biological factors (growth factors, cytokines) to relax the fibrotic capsule rather than mechanically removing or incising it. This substitution eliminates surgical invasiveness while maintaining treatment effectiveness.
Solution Approach 2:
The patent introduces platelet-rich plasma or platelet-rich fibrin as an intermediary substance between the treatment goal and the capsular contracture. These platelet-based products serve as mediators that deliver therapeutic factors directly to the contractured tissue, enabling non-invasive relaxation of the capsule through biochemical mechanisms rather than direct surgical manipulation.
2Area of stationary object
If platelet-based product is injected and spread manually, then the product reaches the contracture tissue, but the distribution may be uneven
Solution Approach 1:
The patent employs acoustic sound waves (ultrasound) to enhance the distribution of injected platelet-based products. The acoustic energy creates mechanical vibrations that promote uniform dispersion of the PRP or PRF throughout the capsular contracture tissue, ensuring even coverage and maximizing therapeutic effect across the entire treated area.
3Reliability
If multiple treatment sessions are administered, then the contracture relaxation is enhanced, but the treatment time increases
Solution Approach 1:
The patent employs periodic treatment sessions spaced one to two weeks apart, delivering platelet-based products in controlled intervals. This periodic administration allows cumulative therapeutic effects to build while maintaining optimal platelet activity levels, achieving enhanced contracture relaxation through repeated biochemical stimulation rather than a single prolonged intervention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively reduces capsular contracture severity by at least one Baker grade within 30 days, providing a less invasive alternative to surgical interventions.
Implementation Method 1
spreading the injected platelet-based product under the skin by manipulation with or without application of acoustic sound waves
Implementation Method 2
applying the platelet-based product to the patient's skin adjacent to said capsular contracture and inducing the transdermal absorption of the platelet-based product into the skin with pulsed electric currents
Data Source
AI summary
Methods and products for treating capsular contractures of breast implants including (1) obtaining a platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) fraction from a patient who exhibits capsular contracture of a breast implant; and (2) applying the PRP or PRF fraction to said capsular contracture, thereby relaxing the capsular contracture.

